Evusheld COVID Prevention

Evusheld Prophylactic Medication 

Evusheld is an investigational medicine used for the most vulnerable patient populations to be used before COVID exposure. It is a prophylactic medication designed to prevent infection. It is not a treatment for COVID. 

Who Qualifies for Evusheld?

Adults and adolescents age 12 and older who are not currently infected with COVID-19 and who fall into one of two categories below qualify for Evusheld:

  1. Those who have a moderately to severely compromised immune system due to a medical condition, or due to taking immunosuppressive medications or treatments, who therefore may not mount an adequate immune response to COVID-19 vaccination. Medical conditions that qualify include but are not limited to the following:
    • Active treatment for solid tumor and hematologic malignancies
    • Receipt of solid-organ transplant and taking immunosuppressive therapy
    • Receipt of chimeric antigen receptor (CAR)-T-cell or hematopoietic stem cell transplant (within 2 years of transplantation or taking immunosuppression therapy)
    • Moderate or severe primary immunodeficiency (e.g., DiGeorge syndrome, Wiskott-Aldrich syndrome)
    • Advanced or untreated HIV infection 
    • Active treatment with high-dose corticosteroids (i.e., ≥20 mg prednisone or equivalent per day when administered for ≥2 weeks), alkylating agents, antimetabolites, transplant-related immunosuppressive drugs, cancer chemotherapeutic agents classified as severely immunosuppressive, tumor-necrosis (TNF) blockers, and other biologic agents that are immunosuppressive or immunomodulatory (e.g., B-cell depleting agents)
  1. Those who have a history of severe adverse reactions to a COVID-19 vaccine and/or components of those vaccines, and are therefore not eligible (or advised against getting) for the COVID vaccine

How Much Does Evusheld Cost

Evusheld is not an alternative to vaccine for the average person. It is an additional tool to fight COVID that is designed for a specific patient population. More information can be found in this patient fact sheet.

Innovative COVID accepts most major insurance plans, and 90 percent of people who get this treatment will not get a bill or pay for the evaluation for antivirals or monoclonal antibody treatment. If you do not have medical insurance, or if we do not accept your medical insurance plan, you will be asked to self-pay for your evaluation and treatment. The self-pay cost for Evusheld is $250.